Cardiovascular drugs. Dofetilide

Circulation. 2000 Nov 21;102(21):2665-70. doi: 10.1161/01.cir.102.21.2665.
No abstract available

Publication types

  • Review

MeSH terms

  • Action Potentials / drug effects
  • Administration, Oral
  • Animals
  • Anti-Arrhythmia Agents / administration & dosage*
  • Anti-Arrhythmia Agents / adverse effects
  • Anti-Arrhythmia Agents / pharmacokinetics*
  • Atrial Fibrillation / drug therapy*
  • Atrial Flutter / drug therapy
  • Controlled Clinical Trials as Topic
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Electrocardiography / drug effects
  • Electrophysiologic Techniques, Cardiac
  • Humans
  • Phenethylamines / administration & dosage*
  • Phenethylamines / adverse effects
  • Phenethylamines / pharmacokinetics*
  • Potassium / metabolism
  • Potassium Channel Blockers
  • Potassium Channels / metabolism
  • Reaction Time / drug effects
  • Sulfonamides / administration & dosage*
  • Sulfonamides / adverse effects
  • Sulfonamides / pharmacokinetics*
  • Treatment Outcome
  • Ventricular Fibrillation / drug therapy

Substances

  • Anti-Arrhythmia Agents
  • Phenethylamines
  • Potassium Channel Blockers
  • Potassium Channels
  • Sulfonamides
  • dofetilide
  • Potassium